A160S (p.Ala160Ser) variant of BRD3 (Bromodomain-containing protein 3)
A160S (p.Ala160Ser) in BRD3 (Bromodomain-containing protein 3) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.18 / 1. The record also includes population frequency data.
A160S (p.Ala160Ser) variant details
- p.Ala160Ser
- TOPMed rs1830297222
- Missense
- Variant Prioritization Score for Impact Estimate 0.177
- REVEL 0.05
- CADD 2.05
- PolyPhen-2 0.00
- SIFT 0.64
- Population evidence available